Caveats associated with the use of human cervical tissue for HIV and microbicide research

AIDS

Volumn 24, Issue 1, 2010, Pages 1-4

  Anderson, Deborah J ^a   Pudney, Jeffrey ^a   Schust, Danny J ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANDROGEN; ESTROGEN; GESTAGEN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; MEDROXYPROGESTERONE ACETATE; POVIDONE IODINE; PROGESTERONE;

CELL MIGRATION; CELL VIABILITY; DYSMENORRHEA; ENDOMETRIOSIS; EXPLANT; HORMONAL CONTRACEPTION; HORMONAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MEDICAL RESEARCH; NONHUMAN; NOTE; PELVIS PAIN SYNDROME; PRACTICE GUIDELINE; PRIORITY JOURNAL; TARGET CELL; TISSUE CULTURE; UTERINE CERVIX; UTERINE CERVIX EPITHELIUM; UTERINE ENDOCERVIX; UTERUS MYOMA; VAGINA BLEEDING; VIROGENESIS; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; ANTI-INFECTIVE AGENTS; BIOMEDICAL RESEARCH; CERVIX UTERI; FEMALE; HIV INFECTIONS; HUMANS;

EID: 73649108902     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328333acfb     Document Type: Note

References (26)

1. Thomas C. Roadblocks in HIV research: five questions. Nat Med 2009; 15:855-859.
2. Collins KB, Patterson BK, Naus GJ, Landers DV, Gupta P. Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract. Nat Med 2000; 6:475-479.
3. Greenhead P, Hayes P, Watts PS, Laing KG, Griffin GE, Shattock RJ. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J Virol 2000; 74:5577-5586.
4. Maher D, Wu X, Schacker T, Horbul J, Southern P. HIV binding, penetration, and primary infection in human cervicovaginal tissue. Proc Natl Acad Sci U S A 2005; 102:11504-11509.
5. Cummins JE Jr, Guarner J, Flowers L, Guenthner PC, Bartlett J, Morken T, et al. Preclinical testing of candidate topical micro-bicides for antihuman immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture. Anti-microb Agents Chemother 2007; 51:1770-1779.
6. Vercellini P, Somigliana E, Vigano P, Abbiati A, Barbara G, Crosignani PG. Endometriosis: current therapies and new pharmacological developments. Drugs 2009; 69:649-675.
7. Lethaby AE, Vollenhoven BJ. An evidence-based approach to hormonal therapies for premenopausal women with fibroids. Best Pract Res Clin Obstet Gynaecol 2008; 22:307-331.
8. Dupont A, Dupont P, Belanger A, Mailoux J, Cusan L, Labrie F. Hormonal and biochemical changes during treatment of endometriosis with the luteinizing hormone-releasing hormone (LH-RH) agonist [D-Trp6, des-Gly-NH2(10)]LH-RH ethy-lamide. Fertil Steril 1990; 54:227-232.
9. Kaplan JC, Crawford DC, Durno AG, Schooley RT. Inactivation of human immunodeficiency virus by Betadine. Infect Control 1987; 8:412-414.
10. Wira CR, Fahey JV. A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 2008; 22:1909-1917.
11. Howell AL, Asin SN, Yeaman GR, Wira CR. HIV-1 infection of the female reproductive tract. Curr HIV/AIDS Rep 2005; 2:35-38.
12. Zhang Z, Schuler T, Zupancic M, Wietgrefe S, Staskus KA, Reimann KA, et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4R T cells. Science 1999; 286:1353-1357.
13. Miller CJ, Li Q, Abel K, Kim EY, Ma ZM, Wietgrefe S, et al. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol 2005; 79:9217-9227.
14. Moench TR, Chipato T, Padian NS. Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices. AIDS 2001; 15:1595-1602.
15. Pudney J, Quayle AJ, Anderson DJ. Immunological microenvir-onments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod 2005; 73:1253-1263.
16. Larsen CP, Steinman RM, Witmer-Pack M, Hankins DF, Morris PJ, Austyn JM. Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 1990; 172:1483-1493.
17. Brajtburg J, Bolard J. Carrier effects on biological activity of amphotericin B. Clin Microbiol Rev 1996; 9:512-531.
18. Bestman-Smith J, Desormeaux A, Tremblay MJ, Bergeron MG. Targeting cell-free HIV and virally-infected cells with anti-HLA-DR immunoliposomes containing amphotericin B. AIDS 2000; 14:2457-2465.
19. Richardson-Harman N, Lackman-Smith C, Fletcher PS, Anton PA, Bremer JW, Dezzutti CS, et al. Multisite comparison of anti-HIV microbicide activity in explant assays using a novel end-point analysis. J Clin Microbiol 2009 [Epub ahead of print].
20. Shattock RJ, Griffin GE, Gorodeski GI. In vitro models of mucosal HIV transmission. Nat Med 2000; 6:607-608.
21. Gupta P, Ratner D, Patterson BK, Kulka K, Rohan LC, Parniak MA, et al. Use of frozen-thawed cervical tissues in the organ culture system to measure anti-HIV activities of candidate microbicides. AIDS Res Hum Retroviruses 2006; 22:419-424.
22. Grant RM, Hamer D, Hope T, Johnston R, Lange J, Lederman MM, et al. Whither or wither microbicides? Science 2008; 321:532-534.
23. Ayehunie S, Cannon C, Lamore S, Kubilus J, Anderson DJ, Pudney J, Klausner M. Organotypic human vaginal-ectocervi-cal tissue model for irritation studies of spermicides, micro-bicides, and feminine-care products. Toxicol In Vitro 2006; 20:689-698.
24. Bobardt MD, Chatterji U, Selvarajah S, Van der Schueren B, David G, Kahn B, Gallay PA. Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells. J Virol 2007; 81:395-405.
25. Bouschbacher M, Bomsel M, Verronese E, Gofflo S, Ganor Y, Dezutter-Dambuyant C, Valladeau J. Early events in HIV transmission through a human reconstructed vaginal mucosa. AIDS 2008; 22:1257-1266.
26. Stoddard E, Ni H, Cannon G, Zhou C, Kallenbach N, Malamud D, Weissman D. gp340 promotes transcytosis of human immunodeficiency virus type 1 in genital tract-derived cell lines and primary endocervical tissue. J Virol 2009; 83:8596-8603.